Your child has a condition called Myopia or Nearsightedness. This means that your child’s vision close up is clear but far away is blurry. Myopia will likely continue to increase until he/she is approximately twenty or twenty-one years of age. As this occurs, your child’s vision will likely get significantly worse every six months to a year.
High myopia is scientifically proven to be associated with an increased risk of developing sight threatening eye diseases later in life such as cataracts, glaucoma, macular degeneration and retinal detachment.*
Your child’s nearsightedness will likely continue to progress even if glasses or soft contact lenses are worn on a regular basis to correct your child’s nearsightedness. Traditional glasses or contact lenses do not slow down the progression of myopia. That’s our goal - to slow down myopia progression.
There are four therapies for slowing down myopia progression. Regulatory approval for each therapy varies from country to country. The therapies are Orthokeratology (Ortho-K), Atropine Drops, Specialty Dual Focused Contact Lenses, or Myopia Spectacles.
Orthokeratology (Ortho-K) is the use of specially designed and fitted contact lenses to gently reshape the cornea overnight which enables clear vision without contacts or glasses the next morning.
Atropine Eye Drops are low dose eye drops administered at bedtime. Atropine drops are approved by regulatory authorities such as the FDA but not for myopia management indication
Specialty Daytime Dual Focused Soft Contact Lenses worn during the day, such as MiSight and
Myopia Spectacles such as MiyoSmart are specially designed glasses worn during the day.